Published in
Taylor and Francis Group, European Clinical Respiratory Journal, 1(5), p. 1536097, 2018
DOI: 10.1080/20018525.2018.1536097
Links
Tools
Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma – a systematic review and meta-analysis
Journal article published in 2018 by
Daniel P. Henriksen 
,
Uffe Bodtger ,
Kirsten Sidenius,
Niels Maltbaek,
Lars Pedersen ,
Hanne Madsen,
Ehm A. Andersson,
Ole Norgaard ,
Louise Klokker Madsen ,
Bo L. Chawes
,
Uffe Bodtger ,
Kirsten Sidenius,
Niels Maltbaek,
Lars Pedersen ,
Hanne Madsen,
Ehm A. Andersson,
Ole Norgaard ,
Louise Klokker Madsen ,
Bo L. Chawes
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 